T. Rowe Price Associates’s Solidion Technology STI Stock Holding History

T. Rowe Price Associates’s Portfolio STI Stock Details STI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-632	Closed	-$4K	–	3163
2025 Q1	$4K	Hold	632	–	–	﹤0.01%	3034
2024 Q4	$22K	Buy	+632	New	+$13.1K	﹤0.01%	2989

Other funds holding STI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

T. Rowe Price Associates's STI Position: Q2 2025 in Review

T. Rowe Price Associates sold out of Solidion Technology (STI) in Q2 2025, closing a stake of 632 shares — an estimated $4K sold.

T. Rowe Price Associates first reported a position in STI in Q4 2024 and held it in 2 quarters. The position peaked at $22K in Q4 2024. 19 funds tracked by Wall St. Rank hold STI as of Q2 2025.

T. Rowe Price Associates reported no remaining Solidion Technology position as of Q2 2025 after selling out during the quarter.
T. Rowe Price Associates sold 632 Solidion Technology shares in Q2 2025, an estimated $4K.
T. Rowe Price Associates first reported a position in Solidion Technology in Q4 2024 and held it in 2 quarters.
T. Rowe Price Associates's Solidion Technology position peaked at $22K in Q4 2024.
19 funds tracked by Wall St. Rank held Solidion Technology as of Q2 2025.

Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.